Fulcrum Therapeutics, Inc. (FULC)
3.51
+0.07
(+2.03%)
USD |
NASDAQ |
Jun 09, 16:00
3.51
0.00 (0.00%)
After-Hours: 19:11
Fulcrum Therapeutics SG&A Expense (Quarterly) : 8.102M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.21M |
| CNBX Pharmaceuticals, Inc. | 0.073M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 19.10M |
| Definium Therapeutics, Inc. | 17.74M |